ACTIVE

CLINIMETRICS

Financial year 2025 · Closed on 31/12/2025

Net result24,4 M €-85,2 %over 1 year

Revenue308,2 k €+3,2 %over 1 year

Equity192,5 M €+14,5 %over 1 year

Identity

Source · BCE/KBO

CLINIMETRICS is a Public limited company incorporated in 1985. Its main activity is: Market research and public opinion polling. Its registered office is in Uccle.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0426.756.052
Incorporation: 10/01/1985
Legal form: Public limited company
Registered office: Rue de Percke 76
1180 Uccle · BruxellesSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

73200Market research and public opinion polling· main 73200Market research and public opinion polling 74131Specialised design activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	308,2 k €	+3.2%	298,7 k €		–		–		–
EBITDA	47,4 k €	+189%	-53,1 k €	-117%	322 k €	+11.9%	287,7 k €	+35.1%	212,9 k €
Operating result	-49,6 k €	+65.9%	-145,4 k €	-166%	221,5 k €	+14.4%	193,6 k €	+198%	-197,4 k €
Net result	24,4 M €	-85.2%	165,3 M €	+14436%	1,1 M €	+604%	161,4 k €	+237%	-118,3 k €
Balance sheet
Equity	192,5 M €	+14.5%	168,1 M €	+1174%	13,2 M €	+9.4%	12,1 M €	+1.4%	11,9 M €
Total assets	197,7 M €	+12.8%	175,3 M €	+1027%	15,6 M €	+4.2%	14,9 M €	+3.0%	14,5 M €
Cash	796 k €	-93.0%	11,3 M €	+324%	2,7 M €	-5.3%	2,8 M €	+132%	1,2 M €
Debts	5,2 M €	-27.3%	7,1 M €	+207%	2,3 M €	-18.7%	2,9 M €	+10.3%	2,6 M €
Other
Workforce	–		–		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CYCO INVEST1023.271.806Represented by Mathieu Buyse	Director01/07/2025 → 25/06/2029
HETAFIN0454.892.881Represented by Henri Tassenoy	Director01/07/2025 → 25/06/2029
NITYA1019.934.214Represented by Céline Buyse	Director01/07/2025 → 25/06/2029
Marc BUYSE	Director06/05/2024 → 25/06/2029Managing director23/06/2013 → 2024 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CELINE BUYSE	Directorlisted until the 2023 accounts
Henri TASSENOY	Director06/05/2024 → 2024 accounts

Other companies at this address

Rue de Percke 76 1180 Uccle

Company	CBE no.
NITYA BOYS● Active	1038.890.883

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	13/08/2025	25/07/2024	06/08/2023	22/08/2022	20/07/2021
General meeting	29/06/2026	14/07/2025	15/07/2024	26/06/2023	27/06/2022	28/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/06/2026	31/08/2026	French	PDF
Full model	31/12/2024	14/07/2025	13/08/2025	French	PDF
Micro model	31/12/2023	15/07/2024	25/07/2024	French	PDF
Micro model	31/12/2022	26/06/2023	06/08/2023	French	PDF
Micro model	31/12/2021	27/06/2022	22/08/2022	French	PDF
Micro model	31/12/2020	28/06/2021	20/07/2021	French	PDF
Micro model	31/12/2019	22/06/2020	05/08/2020	French	PDF
Micro model	31/12/2018	24/06/2019	31/07/2019	French	PDF
Micro model	31/12/2017	25/06/2018	06/08/2018	French	PDF
Micro model	31/12/2016	26/06/2017	05/07/2017	French	PDF
Abridged model	31/12/2015	27/06/2016	27/06/2016	French	PDF
Abridged model	31/12/2014	22/06/2015	29/07/2015	French	PDF
Abridged model	31/12/2013	23/06/2014	19/08/2014	French	PDF
Abridged model	31/12/2012	24/06/2013	12/08/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	27/07/2012	French	PDF
Abridged modelCorrection	31/12/2010	27/06/2011	30/08/2011	French	PDF
Abridged model	31/12/2010	27/06/2011	28/07/2011	French	PDF
Abridged model	31/12/2009	29/06/2010	09/08/2010	French	PDF
Abridged model	31/12/2008	22/06/2009	29/07/2009	French	PDF
Abridged model	31/12/2007	23/06/2008	18/07/2008	French	PDF
Abridged model	31/12/2006	25/06/2007	30/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CYCO INVEST1023.271.806Represented by Mathieu Buyse	Director01/07/2025 → 25/06/2029
HETAFIN0454.892.881Represented by Henri Tassenoy	Director01/07/2025 → 25/06/2029
NITYA1019.934.214Represented by Céline Buyse	Director01/07/2025 → 25/06/2029
Marc BUYSE	Director06/05/2024 → 25/06/2029Managing director23/06/2013 → 2024 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CELINE BUYSE	Directorlisted until the 2023 accounts
Henri TASSENOY	Director06/05/2024 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office19/01/2026
SIEGE SOCIAL
PDF
Mandates04/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates13/05/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
PDF
Mandates19/03/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates22/09/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates30/11/2018
DEMISSIONS, NOMINATIONS
PDF
Mandates29/03/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates18/02/2013
OBJET - DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

HETAFIN

NITYA

CYCO INVEST

Marc BUYSE

Céline BUYSE

Mathieu BUYSE

Henri TASSENOY

Henry TASSENOY

VALERIE VANDERMOTTEN

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

CLINIMETRICS

Rue de Percke 76, 1180 UccleCentenaire 5e avenue 5, 1332 Genval

Director

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue de Percke 76, 1180 UccleCurrent	accounts 2025	Accounts 2025 · 2026-00472939
Centenaire 5e avenue 5, 1332 Genval	accounts 2021 → 2024	Accounts 2024 · 2025-00374828

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
CLINIMETRICSCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00472939

Events

2025
Annual accounts 202524,4 M €↓
2024
Annual accounts 2024165,3 M €↑
01/01/2024
nominationCéline BUYSE · administratrice
2023
Annual accounts 20231,1 M €↑
2022
Annual accounts 2022161,4 k €↑
2021
Annual accounts 2021-118,3 k €↓
2020
Annual accounts 20201,4 M €↓
2019
Annual accounts 20193,3 M €↑
2018
Annual accounts 2018180,7 k €↓
2017
Annual accounts 20176,3 M €↑
2016
Annual accounts 2016188,4 k €↑
2015
Annual accounts 201512,5 k €↓
2014
Annual accounts 2014313 k €↑
2013
Annual accounts 2013123,5 k €↑
2012
Annual accounts 201255,3 k €↑
2011
Annual accounts 201140,9 k €↑
2010
Annual accounts 201011,6 k €↓
2009
Annual accounts 200934,8 k €↑
2008
Annual accounts 20081,1 k €↓
2007
Annual accounts 200722,8 k €↑
2006
Annual accounts 20063,4 k €
10/01/1985
IncorporationPublic limited company

CLINIMETRICS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events